Luis Sanay | Head, Investor Relations |
Dr. Jeffrey Dayno | President and CEO |
Jeffrey Dierks | Chief Commercial Officer |
Dr. Kumar Budur | Chief Medical Officer |
Sandip Kapadia | Chief Financial Officer |
Alex Sklar | Raymond James |
David Amsellem | Piper Sandler |
Francois Brisebois | Oppenheimer |
Graig Suvannavejh | Mizuho Securities |
Jason Gerberry | Bank of America |
Corinne Jenkins | Goldman Sachs |
Charles Duncan | Cantor Fitzgerald |
Good morning. My name is Todd, and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony Biosciences Second Quarter 2023 Financial Results Conference Call. All participant lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session.